GENETIC AORTOPATHIES & LARGE-VESSEL VASCULITIS

Moderator(s)

• 

  Jade Hiramoto, MD, MAS

  Professor of Surgery
  University of California San Francisco
  Vascular Surgery
  San Francisco, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Sean Lyden, MD

  Chairman
  Cleveland Clinic
  Vascular Surgery
  Cleveland, Ohio, United States

  Disclosure(s): Abbott Vascular: Consultant
  Boston Scientific: Consultant
  Contego: Consultant
  Cordis: Consultant
  Endologix: Consultant
  Gore and Associates: Consultant
  InspireMD: Consultant
  Medtronic: Consultant
  Nectero: Consultant
  Penumbra: Consultant
  Shockwave: Consultant
  Vivasure: Consultant

Panel(s)

• 

  J. Fritz Angle, MD

  Professor of Radiology
  University of Virginia
  Interventional Radiology
  Charlottesville, Virginia, United States

  Disclosure(s): Endoron: Consultant
• 

  Joshua Beckman, MD

  Chief, Division of Vascular Medicine
  UT Southwestern Medical Center
  Vascular Medicine
  Dallas, Texas, United States

  Disclosure(s): Janacare: Stockholder - Privately-held company
  Medtronic: Consultant
  Merck: Consultant
  Novartis: Consultant
  Novo Nordisk: Consultant
  Regeneron: Consultant
  tourmaline: Consultant
• 

  Daniella Kadian-Dodov, MD

  Associate Professor of Medicine
  Icahn School of Medicine at Mount Sinai
  Vascular Medicine
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Boston Scientific: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Zevra Therapeutics: Advisory Board
• 

  Sherene Shalhub, MD, MPH

  Professor of Surgery
  Oregon Health & Science University
  Vascular Surgery
  Portland, Oregon, United States

  Disclosure(s): No financial relationships to disclose
• 

  Sara Zettervall, MD, MPH

  Associate Professor
  University of Washington
  Seattle, Washington, United States

  Disclosure(s): Cook Medical: Consultant
  Gore and Associates: Advisory Board; Consultant
  Terumo: Consultant

Presentations:

• 10:30am - 10:39am PT

  Genetic Aortopathies: Status of Testing in 2025
  

  Speaker: Sherene Shalhub, MD, MPH – Oregon Health & Science University
• 10:39am - 10:48am PT

  Genetic Aortopathies: When Is Endo Appropriate?
  

  Speaker: Sara L. Zettervall, MD, MPH – University of Washington
• 10:48am - 10:57am PT

  The Long-Term Effects of Aortic Grafts
  

  Speaker: Joshua Beckman, MD – UT Southwestern Medical Center
• 10:57am - 11:06am PT

  Surgery vs Endo and Timing of Treatment for Large-Vessel Vasculitis
  

  Speaker: J. Fritz Angle, MD – University of Virginia
• 11:06am - 11:15am PT

  Long-Term Nonoperative Management of Patients With Genetic Aortopathies
  

  Speaker: Daniella Kadian-Dodov, MD – Icahn School of Medicine at Mount Sinai
• 11:15am - 11:30am PT

  Panel Discussion